Approval · Notice of Compliance 23531 · 2020
ONSTRYV: Notice of Compliance 23531
Issued April 29, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23531
- Date
- April 29, 2020
- Company
- Valeo Pharma Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to the product monograph in response to aadvisement letter
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONSTRYV | Not yet assigned | — |
Medicinal ingredients
- SAFINAMIDE 100 MG per TAB
- SAFINAMIDE 50 MG per TAB